Human Papillomavirus Testing in Head and Neck Carcinomas | Guidelines International Network (GIN)

Collection

MeSH Terms

Laryngeal Neoplasms (C04.588.443.665.481); Neoplasms by Histologic Type (C04.557); Diagnosis (E01); Diagnostic Techniques and Procedures (E01.370); Neoplasms (C04); Head and Neck Neoplasms (C04.588.443); Mouth Neoplasms (C04.588.443.591); Otorhinolaryngologic Neoplasms (C04.588.443.665); Viruses (B04); DNA Viruses (B04.280); Papillomaviridae (B04.280.535); Alphapapillomavirus (B04.280.535.050); Human papillomavirus 6 (B04.280.535.050.606); Human papillomavirus 16 (B04.280.535.050.616); Human papillomavirus 18 (B04.280.535.050.618); Human papillomavirus 31 (B04.280.535.050.631); Human papillomavirus 11 (B04.280.535.050.606.611); Tumor Virus Infections (C04.925); Pharyngeal Neoplasms (C04.588.443.665.710)

Keywords

head and neck carcinomas, hpv, human papillomavirus, oropharyngeal squamous cell carcinoma, opscc,

Record Publish Year

Original: 2017
Update: 2025

Publication Date

Original: 18-Dec-17
Update: 24-Mar-25

Guideline Contact

Tanja Kalicanin (tkalica@cap.org)

Publication Scope

assessment

Countries of Application

United States

Guideline Publication Status

Published

Languages

English

Authors

CAP (US)

Publication Year

2025